Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy.

X Thomas; Qh Le; S de Botton; E Raffoux; Y Chelghoum; C Pautas; F Dreyfus; N Dhedin; A Vekhoff; J Troncy

doi:10.1080/10428190500084837

Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy.

NobleID: NI1P89W70R78S52
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/3132CFAD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3132CFAD.svg?ark=w1%2F20260515%2F3132CFAD&value=id)](https://nobleid.org/work/w1/20260515/3132CFAD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy.

NobleID: NI1P89W70R78S52
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/3132CFAD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3132CFAD.svg?ark=w1%2F20260515%2F3132CFAD&value=id)](https://nobleid.org/work/w1/20260515/3132CFAD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work